Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
35.65
+0.64 (1.84%)
Feb 6, 2026, 4:00 PM EST - Market closed
HRTS Holdings Information
HRTS is an equity ETF with a total of 45 individual holdings. The top holdings are Eli Lilly and Company stock at 10.06%, Roche Holding AG at 5.43%, Johnson & Johnson at 4.81%, AstraZeneca at 4.50%, and Merck & Co. at 4.24%.
Total Holdings
45
Top 10 Percentage
47.29%
Asset Class
Equity
ETF Category
Health
Assets
55.57M
PE Ratio
23.54
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 10.06% |
| 2 | RHHBY | Roche Holding AG | 5.43% |
| 3 | JNJ | Johnson & Johnson | 4.81% |
| 4 | LON: AZN | AstraZeneca PLC | 4.50% |
| 5 | MRK | Merck & Co., Inc. | 4.24% |
| 6 | TMO | Thermo Fisher Scientific Inc. | 4.20% |
| 7 | GILD | Gilead Sciences, Inc. | 3.76% |
| 8 | UNH | UnitedHealth Group Incorporated | 3.65% |
| 9 | SWX: NOVN | Novartis AG | 3.38% |
| 10 | ABT | Abbott Laboratories | 3.27% |
| 11 | MDT | Medtronic plc | 3.09% |
| 12 | DHR | Danaher Corporation | 3.09% |
| 13 | ABBV | AbbVie Inc. | 2.89% |
| 14 | VRTX | Vertex Pharmaceuticals Incorporated | 2.82% |
| 15 | CPH: NOVO.B | Novo Nordisk A/S | 2.62% |
| 16 | BSX | Boston Scientific Corporation | 2.58% |
| 17 | MCK | McKesson Corporation | 2.16% |
| 18 | BMY | Bristol-Myers Squibb Company | 2.14% |
| 19 | AMGN | Amgen Inc. | 2.05% |
| 20 | REGN | Regeneron Pharmaceuticals, Inc. | 2.04% |
| 21 | BBIO | BridgeBio Pharma, Inc. | 1.92% |
| 22 | RVMD | Revolution Medicines, Inc. | 1.91% |
| 23 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 1.85% |
| 24 | TEVA | Teva Pharmaceutical Industries Limited | 1.72% |
| 25 | CYTK | Cytokinetics, Incorporated | 1.48% |
As of Feb 5, 2026